Vaccines - How they are developed

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/11

encourage image

There's no tags or description

Looks like no tags are added yet.

12 Terms

1
New cards

What are the two many stages?

  1. Pre-clinical stage

  2. Clinical stage


2
New cards

Pre-clinical stage

  1. Vaccine development and design

  2. In vitro testing (laboratory testing)

  3. In vivo testing (animal testing)

  4. Analysis and Evaluation


3
New cards

Vaccine development and design

  • Scientists identify the pathogen (virus or bacterium) that causes the disease.

  • They identify suitable antigens that could trigger an immune response.

  • A vaccine candidate is developed using an appropriate technology, such as mRNA, a proteinsubunitor a weakened/inactivated pathogen.


4
New cards

In vitro testing

  • The vaccine is tested on cells and tissues in the laboratory.

  • Scientists investigate whether it can stimulate an immune response.

  • They assess how cells respond to the vaccine and look for potential harmful effects.


5
New cards

In vivo testing

  • The vaccine is tested in suitable animals, such as mice or non-human primates,wherescientifically justified.

  • Scientists investigate whether the vaccine triggers an immune response.

  • They assess its safety, potential toxicity and ability to protect against infection


6
New cards

Analysis and Evaluation

  • Results from laboratory and animal testing are analysed.

  • Scientists assess the vaccine's safety, effectiveness and potential side effects.

  • If the results are promising, the vaccine may be approved by regulators to progress toPhase1 human clinical trials.


7
New cards

What happens after pre-clinical testing?

If the vaccine shows promising enough results, it moves forward to clinical trials for testing in people

8
New cards

What are the stages of clinical trials?

  • Phase 1

  • Phase 2

  • Phase 3

  • Phase 4


9
New cards

Phase 1

  • Giving the vaccine to a small number of healthy people - around 20–100 volunteers

  • Tests whether the vaccine is safe for humans.

  • Identifies any immediate side effects.

  • Investigates the initial immune response.

  • Helps determine an appropriate dosage.

Main aim: To assess safety and identify potential side effects.


10
New cards

Phase 2

  • Involves a larger number of people to test whether the vaccine triggers an immune response

  • 100 - 300 volunteers

  • includes trial participants who have characteristics (such as age and physical health) similar to the intended recipients for the vaccine

  • They can also include groups of people from diverse backgrounds to ensure representation across different populations

  • Investigates the correct dosage and vaccination schedule.

  • Monitors side effects and safety.

  • Measures the immune response, such as antibody production.

Main aim: To assess safety further and determine the best dose and schedule.


11
New cards

Phase 3

  • Involves thousands of volunteers, sometimes tens of thousands.

  • Often uses a randomised, controlled trial.

  • Participants may receive either the vaccine or a placebo/comparator.

  • Compares infection or disease rates between groups.

  • Monitors common and less common side effects.

Main aim: To establish whether the vaccine is effective and gather further safety information.


12
New cards